Tlp Group Llc Buys Merck Inc, Pfizer Inc, SPDR Select Sector Fund - Health Care, Sells iShares Nasdaq Biotechnology Index Fund

Investment company Tlp Group Llc (Current Portfolio) buys Merck Inc, Pfizer Inc, SPDR Select Sector Fund - Health Care, sells iShares Nasdaq Biotechnology Index Fund during the 3-months ended 2019Q2, according to the most recent filings of the investment company, Tlp Group Llc. As of 2019Q2, Tlp Group Llc owns 3 stocks with a total value of $0 million. These are the details of the buys and sells.

For the details of TLP GROUP LLC's stock buys and sells, go to https://www.gurufocus.com/guru/tlp+group+llc/current-portfolio/portfolioportfolio

These are the top 5 holdings of TLP GROUP LLC
  1. Merck & Co Inc (MRK) - 263,800 shares, 53.64% of the total portfolio. New Position
  2. Pfizer Inc (PFE) - 226,500 shares, 23.79% of the total portfolio. New Position
  3. SPDR Select Sector Fund - Health Care (XLV) - 100,000 shares, 22.57% of the total portfolio. New Position
  4. iShares Nasdaq Biotechnology Index Fund (IBB) - 0 shares, 0.00% of the total portfolio. Shares reduced by 10000%
New Purchase: Merck & Co Inc (MRK)

Tlp Group Llc initiated holding in Merck & Co Inc. The purchase prices were between $73.19 and $85.51, with an estimated average price of $80.15. The stock is now traded at around $81.37. The impact to a portfolio due to this purchase was 53.64%. The holding were 263,800 shares as of .

New Purchase: Pfizer Inc (PFE)

Tlp Group Llc initiated holding in Pfizer Inc. The purchase prices were between $38.98 and $43.76, with an estimated average price of $41.82. The stock is now traded at around $42.70. The impact to a portfolio due to this purchase was 23.79%. The holding were 226,500 shares as of .

New Purchase: SPDR Select Sector Fund - Health Care (XLV)

Tlp Group Llc initiated holding in SPDR Select Sector Fund - Health Care. The purchase prices were between $85.78 and $93.73, with an estimated average price of $89.84. The stock is now traded at around $92.37. The impact to a portfolio due to this purchase was 22.57%. The holding were 100,000 shares as of .

Sold Out: iShares Nasdaq Biotechnology Index Fund (IBB)

Tlp Group Llc sold out a holding in iShares Nasdaq Biotechnology Index Fund. The sale prices were between $99.98 and $114.93, with an estimated average price of $106.31.



Here is the complete portfolio of TLP GROUP LLC. Also check out:

1. TLP GROUP LLC's Undervalued Stocks
2. TLP GROUP LLC's Top Growth Companies, and
3. TLP GROUP LLC's High Yield stocks
4. Stocks that TLP GROUP LLC keeps buying